A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 65 shares of JAZZ stock, worth $7,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 64 1.56%
Holding current value
$7,981
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$100.57 - $116.37 $100 - $116
1 Added 1.56%
65 $7,000
Q2 2024

Jul 05, 2024

BUY
$103.94 - $118.98 $6,652 - $7,614
64 New
64 $6,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Thurston, Springer, Miller, Herd & Titak, Inc. Portfolio

Follow Thurston, Springer, Miller, Herd & Titak, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thurston, Springer, Miller, Herd & Titak, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thurston, Springer, Miller, Herd & Titak, Inc. with notifications on news.